Model‐Based Evaluation of Proximal Sodium Reabsorption Through SGLT2 in Health and Diabetes and the Effect of Inhibition With Canagliflozin

Publisher： John Wiley & Sons Inc

E-ISSN： 1552-4604|58|3|377-385

ISSN： 0091-2700

Source： JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.58, Iss.3, 2018-03, pp. : 377-385

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of canagliflozin on serum uric acid in patients with type 2 diabetes mellitus

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 4, 2015-04 ,pp. : 426-429

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety of Canagliflozin in Patients with Type 2 Diabetes

By  

Current Drug Safety, Vol. 9, Iss. 2, 2014-07 ,pp. : 127-132

Bentham Science Publishers

Access to resources Recommend Favorite

SGLT2 Inhibitors in Diabetes Mellitus Treatment

By  

Reviews on Recent Clinical Trials, Vol. 12, Iss. 1, 2017-01 ,pp. : 8-18

Bentham Science Publishers

Access to resources Recommend Favorite

A novel approach to control hyperglycemia in type 2 diabetes: Sodium glucose co-transport (SGLT) inhibitors. Systematic review and meta-analysis of randomized trials

By Musso Giovanni   Gambino Roberto   Cassader Maurizio   Pagano Gianfranco  

Annals of Medicine, Vol. 44, Iss. 4, 2012-06 ,pp. : 375-393

Informa Healthcare

Access to resources Recommend Favorite

Effect of SGLT2 inhibitors in a murine model of urinary tract infection with Candida albicans

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 16, Iss. 7, 2014-07 ,pp. : 622-627

John Wiley & Sons Inc

Access to resources Recommend Favorite